정재호 (에이비엘바이오)님 | 한빛사연구자 > 한빛사

에이비엘바이오

최종업데이트 2021.07.12.

Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade
- Clin. Cancer Res., May 14 2024, | https://doi.org/10.1158/1078-0432.CCR-23-2864
- 2024-05
- 의약학
- 한빛사논문
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation
- Mol. Ther., Available online 6 May 2022 | https://doi.org/10.1016/j.ymthe.2022.05.003
- 2022-05
- 의약학
- 한빛사논문
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade
- J. Immunother. Cancer, Online issue publication July 06, 2021, 9:e002428 | doi: 10.1136/jitc-2021-002428
- 2021-07
- 의약학
- 한빛사논문
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes
- Sci. Adv., 15 Jan 2021: Vol. 7, no. 3, eaax3160 | DOI: 10.1126/sciadv.aax3160
- 2021-01
- 생명과학
- 한빛사논문

연구자 ID

저자논문